Highly Pathogenic Avian Influenza, more commonly known as H5N1 or bird flu, claimed its first human victim in the United ...
The antibodies target a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.